Annual Cash & Cash Equivalents
$195.90 M
-$87.00 M-30.75%
December 31, 2023
Summary
- As of February 18, 2025, SGRY annual cash & cash equivalents is $195.90 million, with the most recent change of -$87.00 million (-30.75%) on December 31, 2023.
- During the last 3 years, SGRY annual cash & cash equivalents has fallen by -$122.00 million (-38.38%).
- SGRY annual cash & cash equivalents is now -49.76% below its all-time high of $389.90 million, reached on December 31, 2021.
Performance
SGRY Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$221.80 M
+$8.30 M+3.89%
September 30, 2024
Summary
- As of February 18, 2025, SGRY quarterly cash and cash equivalents is $221.80 million, with the most recent change of +$8.30 million (+3.89%) on September 30, 2024.
- Over the past year, SGRY quarterly cash and cash equivalents has stayed the same.
- SGRY quarterly cash and cash equivalents is now -59.07% below its all-time high of $541.90 million, reached on March 31, 2021.
Performance
SGRY Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SGRY Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.8% | 0.0% |
| 3 y3 years | -38.4% | -43.1% |
| 5 y5 years | +6.3% | -43.1% |
SGRY Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.8% | at low | -43.1% | +43.3% |
| 5 y | 5-year | -49.8% | +111.3% | -59.1% | +139.3% |
| alltime | all time | -49.8% | +1403.9% | -59.1% | +363.0% |
Surgery Partners Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $221.80 M(+3.9%) |
| Jun 2024 | - | $213.50 M(+15.3%) |
| Mar 2024 | - | $185.20 M(-5.5%) |
| Dec 2023 | $195.90 M(-30.8%) | $195.90 M(-17.0%) |
| Sep 2023 | - | $236.00 M(+33.0%) |
| Jun 2023 | - | $177.40 M(-27.7%) |
| Mar 2023 | - | $245.50 M(-13.2%) |
| Dec 2022 | $282.90 M(-27.4%) | $282.90 M(+82.8%) |
| Sep 2022 | - | $154.80 M(-31.9%) |
| Jun 2022 | - | $227.40 M(-40.0%) |
| Mar 2022 | - | $378.90 M(-2.8%) |
| Dec 2021 | $389.90 M(+22.6%) | $389.90 M(+18.0%) |
| Sep 2021 | - | $330.40 M(-28.9%) |
| Jun 2021 | - | $464.80 M(-14.2%) |
| Mar 2021 | - | $541.90 M(+70.5%) |
| Dec 2020 | $317.90 M(+242.9%) | $317.90 M(-29.4%) |
| Sep 2020 | - | $450.00 M(+37.9%) |
| Jun 2020 | - | $326.30 M(+67.7%) |
| Mar 2020 | - | $194.60 M(+109.9%) |
| Dec 2019 | $92.70 M | $92.70 M(-16.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $111.30 M(-5.2%) |
| Jun 2019 | - | $117.40 M(-17.6%) |
| Mar 2019 | - | $142.50 M(-22.7%) |
| Dec 2018 | $184.30 M(+5.4%) | $184.30 M(+132.9%) |
| Sep 2018 | - | $79.12 M(-17.6%) |
| Jun 2018 | - | $96.07 M(-14.8%) |
| Mar 2018 | - | $112.82 M(-35.5%) |
| Dec 2017 | $174.91 M(+151.0%) | $174.91 M(-12.4%) |
| Sep 2017 | - | $199.70 M(+250.1%) |
| Jun 2017 | - | $57.03 M(+1.9%) |
| Mar 2017 | - | $55.97 M(-19.7%) |
| Dec 2016 | $69.70 M(+20.3%) | $69.70 M(+26.2%) |
| Sep 2016 | - | $55.21 M(+7.0%) |
| Jun 2016 | - | $51.60 M(-61.8%) |
| Mar 2016 | - | $135.05 M(+133.1%) |
| Dec 2015 | $57.93 M(-22.7%) | $57.93 M(+1.9%) |
| Sep 2015 | - | $56.85 M(+18.7%) |
| Jun 2015 | - | $47.91 M(-36.1%) |
| Dec 2014 | $74.92 M(+475.2%) | $74.92 M |
| Dec 2013 | $13.03 M | - |
FAQ
- What is Surgery Partners annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Surgery Partners?
- What is Surgery Partners annual cash & cash equivalents year-on-year change?
- What is Surgery Partners quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Surgery Partners?
- What is Surgery Partners quarterly cash and cash equivalents year-on-year change?
What is Surgery Partners annual cash & cash equivalents?
The current annual cash & cash equivalents of SGRY is $195.90 M
What is the all time high annual cash & cash equivalents for Surgery Partners?
Surgery Partners all-time high annual cash & cash equivalents is $389.90 M
What is Surgery Partners annual cash & cash equivalents year-on-year change?
Over the past year, SGRY annual cash & cash equivalents has changed by -$87.00 M (-30.75%)
What is Surgery Partners quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of SGRY is $221.80 M
What is the all time high quarterly cash and cash equivalents for Surgery Partners?
Surgery Partners all-time high quarterly cash and cash equivalents is $541.90 M
What is Surgery Partners quarterly cash and cash equivalents year-on-year change?
Over the past year, SGRY quarterly cash and cash equivalents has changed by $0.00 (0.00%)